Scarica l'app Stockscreener
11.62
9.64%
-1.24
Dopo l'orario di chiusura:
11.60
-0.02
-0.17%
Precedente Chiudi:
$12.86
Aprire:
$12.7
Volume 24 ore:
7.18M
Relative Volume:
4.36
Capitalizzazione di mercato:
$1.15B
Reddito:
-
Utile/perdita netta:
$-44.84M
Rapporto P/E:
-24.72
EPS:
-0.47
Flusso di cassa netto:
$-44.23M
1 W Prestazione:
-13.93%
1M Prestazione:
-34.54%
6M Prestazione:
+13.92%
1 anno Prestazione:
-10.48%
Intervallo 1D:
$10.98
$12.70
Intervallo di 1 settimana:
$10.98
$14.00
Portata 52W:
$10.01
$18.90
Ars Pharmaceuticals Inc Stock (SPRY) Company Profile
Nome
Ars Pharmaceuticals Inc
Settore
Industria
Telefono
858-771-9307
Indirizzo
11682 EL CAMINO REAL, SUITE 120, SAN DIEGO
Confronta SPRY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SPRY
Ars Pharmaceuticals Inc
|
11.62 | 1.27B | 0 | -44.84M | -44.23M | -0.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Ars Pharmaceuticals Inc Stock (SPRY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2025-02-10 | Iniziato | Oppenheimer | Outperform |
| 2024-08-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-08-12 | Reiterato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | Raymond James | Outperform |
| 2024-03-05 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-02-20 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-09-20 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | Iniziato | Wedbush | Outperform |
| 2023-01-03 | Iniziato | William Blair | Outperform |
| 2022-12-13 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Ars Pharmaceuticals Inc Borsa (SPRY) Ultime notizie
Ranking ARS Pharmaceuticals Inc. among high performing stocks via toolsQuarterly Growth Report & Free Reliable Trade Execution Plans - Newser
Using data models to predict ARS Pharmaceuticals Inc. stock movementJuly 2025 Review & Entry Point Confirmation Alerts - Newser
What machine learning models say about ARS Pharmaceuticals Inc.Market Weekly Review & Daily Stock Trend Watchlist - Newser
Real time pattern detection on ARS Pharmaceuticals Inc. stockIPO Watch & Weekly Chart Analysis and Trade Guides - Newser
Is ARS Pharmaceuticals Inc. forming a bottoming baseLayoff News & Daily Growth Stock Investment Tips - Newser
What machine learning models say about ARS Pharmaceuticals Inc2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
ARS Pharmaceuticals Inc. recovery potential after sell offEntry Point & Low Risk Entry Point Tips - Newser
Quantitative breakdown of ARS Pharmaceuticals Inc. recent moveTreasury Yields & Fast Entry Momentum Trade Alerts - Newser
Technical analysis overview for ARS Pharmaceuticals Inc. stockJuly 2025 Levels & Daily Oversold Bounce Ideas - Newser
How to interpret RSI for ARS Pharmaceuticals Inc. stockBull Run & Technical Entry and Exit Alerts - Newser
Custom watchlist performance reports with ARS Pharmaceuticals Inc.Market Risk Analysis & Growth Oriented Trade Recommendations - Newser
Price momentum metrics for ARS Pharmaceuticals Inc. explained2025 Support & Resistance & High Yield Stock Recommendations - Newser
What MACD and RSI say about ARS Pharmaceuticals Inc.Long Setup & Expert Verified Movement Alerts - Newser
Can ARS Pharmaceuticals Inc. rally from current levelsAnalyst Upgrade & Verified Swing Trading Watchlists - Newser
Custom watchlist performance reports with ARS Pharmaceuticals IncProfit Target & Daily Technical Forecast Reports - Newser
Risk vs reward if holding onto ARS Pharmaceuticals Inc.Oil Prices & Community Verified Trade Signals - Newser
Comparing ARS Pharmaceuticals Inc. in custom built stock radarsCEO Change & Verified Short-Term Plans - Newser
What recovery options are there for ARS Pharmaceuticals Inc.2025 Sector Review & Fast Moving Stock Watchlists - Newser
ARS Pharmaceuticals Faces Wider Loss in Q2, Stirring Market Concerns - StocksToTrade
Trading Bots Trigger Alerts on ARS Pharmaceuticals Inc. Activity getLinesFromResByArray error: size == 0 - thegnnews.com
ARS Pharmaceuticals Down 9% as Lupin Files Generic Neffy Application - AInvest
What the charts say about ARS Pharmaceuticals Inc. today2025 Biggest Moves & AI Driven Stock Reports - Newser
How high can ARS Pharmaceuticals Inc. stock go2025 Top Decliners & Short-Term Swing Trade Alerts - Newser
Applying Elliott Wave Theory to ARS Pharmaceuticals Inc.2025 Growth vs Value & Smart Allocation Stock Reports - Newser
Detecting price anomalies in ARS Pharmaceuticals Inc. with AIJuly 2025 Trade Ideas & Safe Entry Point Alerts - Newser
ARS Pharma drops 9% as Lupin files application for generic neffy - MSN
ARS Pharmaceuticals Faces Financial Struggles as Q2 Loss Exceeds Estimates - StocksToTrade
ARS Pharmaceuticals Plunges 8.7%—What Legal Storm Could Sink Neffy's Future? - AInvest
Ars Pharmaceuticals Inc Azioni (SPRY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):